A simple method to detect biotin interference on immunoassays

Leo Lam 1  and Campbell V. Kyle 2 , 3
  • 1 Department of Chemical Pathology, Labplus, Auckland City Hospital, Auckland, New Zealand
  • 2 Department of Chemical Pathology, Labplus, Auckland City Hospital, Auckland, New Zealand, Phone: + 649 367 4949, ext 22045, Fax: + 649 375 4301
  • 3 Department of Biochemistry, Labtests, Auckland, New Zealand
Leo Lam and Campbell V. Kyle

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1.

    Batista MC, Ferreira CE, Faulhaber AC, Hidal JT, Lottenberg SA, Mangueira CL. Biotin interference in immunoassays mimicking subclinical Graves’ disease and hyperestrogenism: a case series. Clin Chem Lab Med 2017;55:e99–103.

    • Crossref
    • PubMed
    • Export Citation
  • 2.

    Tourbah A, Lebrun-Frenay C, Edan G, Clanet M, Papeix C, Vukusic S, et al. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study. Mult Scler 2016;22:1719–31.

    • Crossref
    • PubMed
    • Export Citation
  • 3.

    Kummer S, Hermsen D, Distelmaier F. Biotin treatment mimicking graves’ disease. N Engl J Med 2016;375:704–6.

    • Crossref
    • PubMed
    • Export Citation
  • 4.

    Wijeratne NG, Doery JC, Lu ZX. Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study. Pathology 2012;44:674–5.

    • PubMed
    • Export Citation
  • 5.

    Meany DL, Jan de Beur SM, Bill MJ, Sokoll LJ. A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations. Clin Chem 2009;55: 1737–9.

    • Crossref
    • PubMed
    • Export Citation
  • 6.

    Diamandis EP, Christopoulos TK. The biotin-(strept)avidin system: principles and applications in biotechnology. Clin Chem 1991;37:625–36.

    • Crossref
    • PubMed
    • Export Citation
  • 7.

    Elston MS, Sehgal S, Du Toit S, Yarndley T, Conaglen JV. Factitious Graves’ disease due to biotin immunoassay interference – a case and review of the literature. J Clin Endocrinol Metab 2016;101:3251–5.

    • Crossref
    • PubMed
    • Export Citation
  • 8.

    Trambas CM, Sikaris KA, Lu ZX. A caution regarding high-dose biotin therapy: misdiagnosis of hyperthyroidism in euthyroid patients. Med J Aust 2016;205:192.

    • Crossref
    • PubMed
    • Export Citation
  • 9.

    Mattman A, DeMarco ML, Wong S, Holmes DT, Lee J. Grave clinicopathologic correlation: a case of hyperthyroxinemia. J Appl Lab Med 2016;1:310–14.

    • Crossref
    • Export Citation
Purchase article
Get instant unlimited access to the article.
$42.00
Log in
Already have access? Please log in.


or
Log in with your institution

Journal + Issues

Clinical Chemistry and Laboratory Medicine ( CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine. CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine. It is one of the leading journals in the field, with an impact factor of over three. CCLM is the official journal of nine national clinical societies and associated with EFLM.

Search